Jun 5 |
Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
|
Jun 4 |
Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety
|
May 21 |
Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse Prevention
|
May 14 |
Silo Pharma to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine
|
Apr 23 |
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
|
Apr 10 |
Silo Pharma set to acquire licensing for Alzheimer’s disease therapeutic
|
Apr 10 |
Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease Therapeutic
|
Apr 9 |
Citizens And 2 Other Stocks Under $3 Insiders Are Buying
|